Inogen | INGN - Cost Of Sales


Inogen reported $39.59M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
AngioDynamics USD 33.15M 208K Feb/2025
AtriCure USD 32.94M 1.72M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Chart Industries USD 775M 7.5M Sep/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 196.2M 700K Sep/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.52B 80M Sep/2025
Orthofix International USD 253.61M 192.05M Dec/2024
Philips EUR 2.81B 417M Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 114.96M 138K Sep/2025
Teleflex USD 461.38M 111.57M Sep/2025
X T L Biopharmaceuticals USD 332K 216K Dec/2024
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025